ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,129, issued on Feb. 3, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"KIF18A inhibitors" was invented by Nuria A. Tamayo (Newbury Park, Calif.), Abhisek Banerjee (Karnataka, India), Jian Jeffrey Chen (San Diego), Matthew Richard Kaller (Ventura, Calif.), Thomas T. Nguyen (Newbury Park, Calif.), Nobuko Nishimura (West Hills, Calif.), Qiufen May Xue (Thousand Oaks, Calif.), John Gordon Allen (Newbury Park, Calif.) and Michael J. Frohn (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Amide compounds of formula (I): as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby in...